About Gilead
Corporate Overview
Leadership
Worldwide Operations
Corporate Responsibility
Partners and Business Development
Products
Medical Information Request
Patient Care
Product Approvals Timeline
Research
Science
Clinical Trials
Investors
Newsroom
Press Releases
Media Inquiries
Media FAQ
Careers
Current Opportunities
Culture
U.S. Benefits
HOME
CONTACT
SITE MAP
SEARCH
Fundamentals - Snapshot
Corporate Governance
Stock Information
Financial Information
Fundamentals
Estimates
Analyst Coverage
SEC Filings
Earnings
Annual Reports
Proxy Online
GAAP to Non-GAAP Reconciliation
News and Events
Email Alerts
Financial FAQ
Contact Information
Print Page
|
E-mail Page
|
Financial Tear Sheet
Snapshot |
Trading Statistics
|
Balance Sheet
|
Income Statement
|
Cash Flow
|
Ratios
Revenue & Earnings
Revenue (mil) (FYE)
4,230.05
Income From Continuing Operations (mil) (FYE)
1,615.30
Income From Total Operations (mil) (FYE)
1,615.30
Diluted EPS From Continuing Operations (FYE)
1.68
Diluted EPS From Total Operations (FYE)
1.68
Dividends
Ex-Dividend Date
Dividend Rate
.00
Yield
.00%
Yield - 5 Year Average
.00
Ratios
Price To Revenue
11.90
Price To Cash Flow
23.07
Price to Book
10.38
Debt To Equity
37.58
Current Ratio
4.11
Growth Rates
5-Year Annual Dividend Growth Rate
.00
5-Year Annual Revenue Growth Rate
55.40
Data Provided by Thomson Financial
